16p11.2 Deletion Syndrome: Clinical Trials

2 trials for 16p11.2 Deletion Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow 16p11.2 Deletion Syndrome: new trials by email Literature Review of 16p11.2 Deletion Syndrome trials Research Report on 16p11.2 Deletion Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion
Arbaclofen, Placebo oral tablet - 16P11.2 Deletion Syndrome
Phase 2UnknownClinical Research Associates, LLC602022-09-012024-05-30
Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
16P11.2 Deletion Syndrome, 16p11.2 Duplications
RecruitingSimons Searchlight1000002010-10-012026-07-23

Narrower conditions

15q24 Microdeletion (1)  ·  Chromosome 15q13.3 Microdeletion Syndrome (1)  ·  Chromosome 17q21.31 Deletion Syndrome (1)  ·  Chromosome 1q21.1 Deletion Syndrome, 1.35-Mb (1)  ·  Chromosome 1q21.1 Duplication Syndrome (1)  ·  Chromosome 2q37 deletion syndrome (1)  ·  Cornea Plana 1 (1)  ·  Cri-du-Chat Syndrome (1)  ·  Epileptic Encephalopathy, Early Infantile, 4 (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Rhabdoid Tumor Predisposition Syndrome 2 (1)

Broader conditions

Abnormalities, Multiple (1)  ·  Chromosome Disorders (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Intellectual Disability (1)  ·  Nervous System Diseases (1)  ·  Nervous System Malformations (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurodegenerative Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Diseases (1)  ·  Peripheral Nervous System Diseases (1)  ·  Polyneuropathies (1)

Interventions

Sugars (1)  ·  arbaclofen placarbil (1)

Sponsors

Clinical Research Associates, LLC (1)  ·  Simons Searchlight (1)

Countries

United States (2)

Top investigators

Cora Taylor, PhD (1)  ·  Paul Wang, MD (1)  ·  Wendy Chung, MD PhD (1)

Results publications

PMID 42080302